Evidence about the use of naltrexone and acamprosate
Rapid weight loss, particularly to Ozempic face, is a common side effect that has caused some patients to develop facial changes, such as sagging or volume loss
This expands the role of these medications far beyond obesity treatment
Despite strong animal results, human longevity evidence is still early, and the risks require careful oversight
Compared to crustaceans, knowledge of major allergens in mollusks remains limited
Side Effects and Timing: Nausea, Injection Site Reactions, and Symptom Management Nausea is the most commonly reported side effect of semaglutide, affecting 20 to 40 percent of patients in early treatment weeks